Home>Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer
Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer
- Impact factors: 7.519
- Publication: npj Breast Cancer
- Author:Yang Ziyan, Feng Jianguo, Jing Ji, Huang Yuan, Ye Wei-Wu, Lei Lei, Wang Xiao-Jia, Cao Wen-Ming
- DOI citation-doi:10.1038/s41523-023-00542-1
- Date:2023-05-09